(Date:7/25/2008)...ivanCotter Releases Results of Fourth Annual Physi...urvey, DETROIT, July 25 /PRNewswire/ -- Sullivan,...rth annual survey of physician on-call pay rates a...y Report. The survey report,with data from 132 he...ian,on-call pay practices and rates paid for 33 ph...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Begin...l/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI ), ...ced today that its subsidiary has commenced commer...psules USP product in the 40mg,strength from its D...on,with the launch, Watson has 180 days of marketi...
(Date:7/25/2008)... McKesson Corporation Executive, Robert J. Reilly,...re/ -- Aethon Inc.,( http://www.aethon.com ), the ...supply chain logistics, today announced that Rober...President -- Chief Financial Officer., Reilly, wh...ger for,McKesson Corporation,s Specialty Pharmacy ...
(Date:7/25/2008)...STON, July 25 /PRNewswire/ -- The Elekta Family of...er treatment solutions at the 2008,American Associ...ing,demonstrating how the joint forces of Elekta,...on therapy planning and delivery solutions that,st...experience for,patients, as well as enhance clinic...
Breaking Medicine News(10 mins):Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 2Health News:Hospital Expenditures for Physician On-Call Pay Rates Nearly Double 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3...arly Online Publication, released on the 5th of Oc...about chronic diseases, has a comprehensive report... article, co-authored // by Union Health Minister ...ctive public-health response to the growing challe...
...litus is an independent risk factor for cardiovasc...s the risk by 2-6 fold relative to nondiabetic sub.../ mellitus patients will die of an atherosclerotic...nfers increased risk for cardiovascular disease, a...
... between diet and health is well recognized, howev...al relationship between a particular dietary compo...ecial interest // particularly for environmental p...he food chain. In recent years, a number of studie...
...ways been looked at by outsiders as the land of my...armonious central key to getting in touch with the... to // this large sub-continent then what meets th...njoyed without a real time experience. Tourism ha...
Other Medicine News:Health News:Strategies to prevent the rising tide of the epidemic of chronic diseases 2Health News:Athletes Are More Prone To Environmental Pollutants Due To Choice Of Diet 2(Date:7/24/2008)... July 24 /- Alexza,Pharmace...t it has initiated,its second Phase 3 clinical tri...n inhalation product candidate being developed for... schizophrenia or bipolar disorder.,Alexza believe...okinetic,(PK) properties resulting from inhaled lo...
(Date:7/24/2008)...ewswire-FirstCall/ -- MacroChem Corporation (OTC,B...Phase 2 clinical trial,involving 37 patients who c...efficacy and safety study of EcoNail, a topical an...s (nail fungus). The composite,primary efficacy en...,negative mycology (negative fungal culture and ne...
(Date:7/23/2008)...RNewswire-USNewswire/ -- The following was,release...nyers, Ranking Member Smith, and Members of the Co...today., Since I appeared before this Committee al...uainted with the talented and dedicated profession...ey do, and I have come to,appreciate that much mor...
(Date:7/23/2008)...-Enabling Work with Protein Therapeutics that ...ystem, CAMBRIDGE, Mass., July 23 /- ...nitiated a corporate growth plan with the,appointm...fficer and the,establishment of its headquarters i...Emlen, M.D., a co-founder of the company who remai...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3ESBATechs Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops 3464 1ESBATechs Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops 3464 2ESBATechs Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops 3464 3Protect Your Adolescents Against More Than Just A Cold This Winter 12551 1Protect Your Adolescents Against More Than Just A Cold This Winter 12551 2Public Health Experts Argue for Integrated Services to Avert 7 Million HIV Infections by 2010 12549 1Public Health Experts Argue for Integrated Services to Avert 7 Million HIV Infections by 2010 12549 2Family Friends and Support Groups Add Picture Messaging to Inspire and Motivate Anywhere Anytime 12547 1Family Friends and Support Groups Add Picture Messaging to Inspire and Motivate Anywhere Anytime 12547 2...ty of Nuclear Medicine Annual Meeting -, WASHINGTO...edics, Inc. , a biopharmaceutical company focused ...r and other serious,diseases, today announced that...pany,s humanized anti-MUC1 monoclonal antibody (hP...-90), in patients with,unresectable and metastatic...
...II Study Provides Further Evidence of,the Signific...ent,of Rheumatoid Arthritis, BASEL, Switzerland, J... the second multinational phase III Actemra,(tocil...dpoint and,showed that a greater proportion of pat...ditional disease modifying drugs (DMARDs),achieved...
Other Medicine Technology:Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 2Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 3Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 4Immunomedics Reports Initial Clinical Results With Hpam4 For,Pancreatic Cancer Therapy 5New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 2New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 3New Data Confirms Significant Improvement of Disease Signs and,Symptoms in Patients with Rheumatoid Arthritis 4...ssional ophthalmic photographer. Integrated flash,...ground illumination, all controlled through a rele...stick, as well as adaptors allowing for the fittin...tal and 35 mm cameras, ensure ophthalmic imaging o...
...ltiplexing platform that uses advanced microarray ...sequence detection and pharmacogenetics applicatio...applied to an open and flexible electronic microar...ntil all tests sites have been utilized. This open...
...c laser platform, combining innovative laser deliv... fast operation, super adjustable Nd:YAG offset an...laser systems. ,The Nidek YC-1800 replaces th... the Joystick "Smart Switch" and One-Touch Lock.,...
epTIPS Filter have an integrated filter made of pure hydrophobic polyethylene without "self-sealing" additives. This filter provides protection against carryover and contamination caused by aerosols,
Medicine Products: